The New Data on Dabigatran: Are We Reassured or Still Questioning?
Bleeding and "mysterious" sginal for MI seen in RE-LY persist. Message: continue to weigh risk vs benefit.
Oral Anticoagulant Therapy and Renal Dysfunction: A Two-way Street?
Study net-net: Account for kidney function when dosing the direct oral anticoagulants -- but also account for an agent's potential renal harm.
TSH Normal, FT4 Trending Up: What Risk for Afib?
Is this patient, status post motor vehicle accident, at risk for developing atrial fibrillation?
Secondary Afib, ICU-Bed 10: Trigger? Rx?
You're finishing rounds on Friday and are called to the ICU to consult on a case of Afib. The patient is a surprise and the residents have questions. Good luck!
Drug-Drug Interactions with DOACs: Proceed with Caution!
Which drugs taken concurrently with the new oral anticoagulants put patients with Afib at greatest increased risk for major bleeding?
Atrial Fibrillation and Type I Diabetes: What's the Link?
A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.
Should We Refer Symptomatic HF Patients for AF Ablation?
That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.
AF Screening Leads the Charge in Cardiology's Digital Revolution
Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?
Could AF Ablation have a "Placebo" Effect?
A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?
Subclinical Atrial Fibrillation Rears its Head, Again
Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?